BACKGROUND: Although symptomatic patients with severe aortic stenosis have a high disease burden and guidelines recommend aortic valve replacement, many are treated conservatively. This study describes to what extent quality of life is changed by aortic valve replacement relative to conservative treatment. METHODS: This observational study followed 132 symptomatic patients with severe aortic stenosis who were subjected to an SF-36v2TM Health Survey. RESULTS: At baseline 84 patients were treated conservatively, 48 were referred for aortic valve replacement. In the conservatively treated group 15 patients died during a mean follow-up of 18 months (Kaplan-Meier survival was 85 % and 72 % at one and 2 years respectively) and 22 patients crossed over to the surgical group. Of the resulting 70 patients in the surgical group 3 patients died during a mean follow-up of 11 months (survival 95 % at 1 year). Physical functioning, vitality and general health improved significantly 1 year after aortic valve replacement. In conservatively treated patients physical quality of life deteriorated over time while general health, vitality and social functioning showed a declining trend. Mental health remained stable in both groups. CONCLUSIONS: Aortic valve replacement improves physical quality of life, general health and vitality in patients with symptomatic severe aortic stenosis. Besides having a low life expectancy, conservatively treated patients experience deterioration of physical quality of life. Health surveys such as the SF-36v2TM can be valuable tools in monitoring the burden of disease for an individual patient and offer additional help in treatment decisions.
BACKGROUND: Although symptomatic patients with severe aortic stenosis have a high disease burden and guidelines recommend aortic valve replacement, many are treated conservatively. This study describes to what extent quality of life is changed by aortic valve replacement relative to conservative treatment. METHODS: This observational study followed 132 symptomatic patients with severe aortic stenosis who were subjected to an SF-36v2TM Health Survey. RESULTS: At baseline 84 patients were treated conservatively, 48 were referred for aortic valve replacement. In the conservatively treated group 15 patients died during a mean follow-up of 18 months (Kaplan-Meier survival was 85 % and 72 % at one and 2 years respectively) and 22 patients crossed over to the surgical group. Of the resulting 70 patients in the surgical group 3 patients died during a mean follow-up of 11 months (survival 95 % at 1 year). Physical functioning, vitality and general health improved significantly 1 year after aortic valve replacement. In conservatively treated patients physical quality of life deteriorated over time while general health, vitality and social functioning showed a declining trend. Mental health remained stable in both groups. CONCLUSIONS: Aortic valve replacement improves physical quality of life, general health and vitality in patients with symptomatic severe aortic stenosis. Besides having a low life expectancy, conservatively treated patients experience deterioration of physical quality of life. Health surveys such as the SF-36v2TM can be valuable tools in monitoring the burden of disease for an individual patient and offer additional help in treatment decisions.
Authors: N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips Journal: J Clin Epidemiol Date: 1998-11 Impact factor: 6.437
Authors: Henning T Baberg; Matthias Dirlich; Axel Laczkovics; Peter Grewe; Waldemar Bojara; Justus de Zeeuw; Torsten T Bauer; Joachim Kugler; Andreas Mügge Journal: J Heart Valve Dis Date: 2004-11
Authors: J S Rumsfeld; D J Magid; M O'Brien; M McCarthy; S MaWhinney; A L Shroyer; T E Moritz; W G Henderson; G K Sethi; F L Grover; K E Hammermeister Journal: Ann Thorac Surg Date: 2001-12 Impact factor: 4.330
Authors: T M Sundt; M S Bailey; M R Moon; E N Mendeloff; C B Huddleston; M K Pasque; H B Barner; W A Gay Journal: Circulation Date: 2000-11-07 Impact factor: 29.690
Authors: Artyom Sedrakyan; Viola Vaccarino; A David Paltiel; John A Elefteriades; Jennifer A Mattera; Sarah A Roumanis; Zhenqiu Lin; Harlan M Krumholz Journal: J Am Coll Cardiol Date: 2003-10-01 Impact factor: 24.094
Authors: M W A van Geldorp; H J Heuvelman; A P Kappetein; J J V Busschbach; D J Cohen; J J M Takkenberg; A J J C Bogers Journal: Neth Heart J Date: 2013-01 Impact factor: 2.380
Authors: Kjersti Oterhals; Rune Haaverstad; Jan Erik Nordrehaug; Geir Egil Eide; Tone M Norekvål Journal: BMJ Open Date: 2017-08-21 Impact factor: 2.692